Reviva Pharmaceuticals Holdings, Inc. (RVPH): Accounting Value of Company

The current share price of Reviva Pharmaceuticals (RVPH) shown on this chart reflects the dynamics of a company developing a comprehensive system for combating mental disorders through the implementation of innovative Brilaroxazine. The current figure stands at 0.02. The business relies on the development of a safe treatment for schizophrenia, which is currently in the clinical testing stage. Meanwhile, pragmatic management ensures data transparency despite the limited capital of this micro-cap.

Book value reflects the value of a company's net assets minus all liabilities, serving as a fundamental indicator of the business's material stability. For Reviva Pharmaceuticals (RVPH), which invests in selective CNS therapy, the book value trend demonstrates the company's ability to fund the development of schizophrenia drugs, confirming the quality of its resource base and protection against default.